Tempus AI's Data Chief Just Filed a Form 4. His Segment Grew 28% Last Quarter.
This sale was non-discretionary, executed to cover tax withholding from RSU vesting.
Overview
Ryan Fukushima, CEO, Data at Tempus AI, Inc. (NASDAQ:TEM), reported the disposition of 41,095 shares of common stock on August 18, according to an SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average sale price ($49.61); post-transaction value based on the August 18 market close ($49.36).
Details
Tempus AI is a healthcare technology company with a market capitalization of $10.7 billion and TTM revenue of $1.4 billion, operating as a leading provider of AI-enabled diagnostic and analytics platforms for precision medicine. The company's integrated platform architecture creates a competitive advantage by combining clinical workflow optimization with proprietary laboratory capabilities and advanced data analytics. With 3,800 employees and headquarters in Chicago, Tempus AI is positioned at the intersection of genomics, artificial intelligence, and clinical diagnostics, though the company is currently in a growth investment phase with negative net income of -$254.4 million TTM.
Source
Originally published at www.fool.com.